Remove FDA Remove Labelling Remove White Paper
article thumbnail

Is Pay-Per-Click Advertising Working in Pharma?

Pharma Marketing Network

Ads must include proper disclosures, balance benefit-risk information, and avoid off-label promotion. For example, tracking a user’s journey from a search ad to a white paper download offers valuable insight into funnel behavior. These formats not only engage users but also comply with FDA guidance when properly developed.

FDA 52
article thumbnail

GE HealthCare’s PET imaging agent gains Alzheimer’s label expansion

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has expanded the indications of an imaging agent developed by GE HealthCare, which will likely put it at the forefront of the Alzheimer’s diagnostics arena. Credit: Utthapon wiratepsupon via Shutterstock. Don’t let policy changes catch you off guard.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Tisento’s MELAS treatment receives fast track status from FDA

Pharmaceutical Technology

Tisento Therapeutics has received fast track designation from the US Food and Drug Administration (FDA) for its investigational oral medicine, zagociguat, for mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS), a rare mitochondrial disease. Credit: Volha_R/Shutterstock.

FDA 52
article thumbnail

FDA approves label updates for BMS’ CAR T cell therapies

Pharmaceutical Technology

June 27, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Label updates have been approved for BMS’ CAR T cell therapies, Breyanzi and Abecma, to treat multiple myeloma. The regulatory agency has also given approval to the removal of the REMS requirement from the product labels. Credit: Saiful52 / Shutterstock.

article thumbnail

FDA approves KalVista’s Ekterly for hereditary angioedema

Pharmaceutical Technology

The US Food and Drug Administration (FDA) has approved KalVista Pharmaceuticals’ Ekterly (sebetralstat) as the first and only oral on-demand medication for acute attacks of hereditary angioedema (HAE) in adults and in children aged 12 years and above. Credit: KalVista Pharmaceuticals/Business Wire.

FDA 122
article thumbnail

Swissmedic approves Novartis’ malaria medicine for babies

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out?

article thumbnail

Chugai and Gero link on antibody drugs for age-related conditions

Pharmaceutical Technology

How will RFK Jr’s American dream for vaccines play out?